Financial News
Press Releases about NM
Novamind to Present at the H.C. Wainwright 2nd Annual Psychedelics Conference on December 6
December 02, 2021
From Novamind Inc.
Via AccessWire
Novamind Reports Fiscal Q1 Financial Results and Operating Highlights
November 29, 2021
From Novamind Inc.
Via AccessWire
Novamind Unveils New Logo and Invests in Unified Brand
November 24, 2021
From Novamind Inc
Via AccessWire
Novamind Signs LOI to Acquire Two Mental Health Clinics in Arizona
November 16, 2021
From Novamind Inc.
Via AccessWire
Novamind Enters New Lease Agreement Responding to Patient Demand
November 12, 2021
From Novamind Inc.
Via AccessWire
Novamind Secures Insurance Coverage for Ketamine from Four Major Payors
November 10, 2021
From Novamind Inc.
Via AccessWire
Exposures
Product Safety
From Novamind Inc.
Via AccessWire
Novamind Reports FY2021 Financial Results and Operating Highlights
November 05, 2021
From Novamind Inc.
Via AccessWire
Exposures
COVID-19
Novamind Announces Cease Trade Order and Delay in Filing Annual Financial Statements
November 04, 2021
From Novamind Inc.
Via AccessWire
Novamind Unveils Stealth Mode Investment in Alto Neuroscience
October 22, 2021
Via AccessWire
Novamind Granted DEA Licenses for Psilocybin Research
October 13, 2021
From Novamind Inc.
Via AccessWire
Novamind to Present at LD Micro and KCSA Conferences
October 08, 2021
From Novamind Inc.
Via AccessWire
Novamind Launches New Psychedelic Palliative Care Program
October 07, 2021
From Novamind Inc.
Via AccessWire
Via AccessWire
Novamind Opens 6th Integrative Psychiatry Clinic, Adds 3rd Clinical Research Site
September 30, 2021
From Novamind Inc.
Via AccessWire
Novamind Announces DTC Eligibility for its Common Shares
September 24, 2021
From Novamind Inc.
Via AccessWire
Novamind Announces Inclusion in NYSE Listed AdvisorShares Psychedelics ETF
September 20, 2021
From Novamind Inc.
Via AccessWire
Novamind to Present at Life Sciences Investor Forum
September 14, 2021
From Novamind Inc.
Via AccessWire
Novamind to Serve as Research Site for Karuna Therapeutics Late-Stage Clinical Trial
September 13, 2021
From Novamind Inc.
Via AccessWire
Novamind Uplists to OTCQB Venture Market
September 09, 2021
Via AccessWire
From Novamind Inc.
Via AccessWire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.